A potential role for angiotensin II in obesity induced cardiac hypertrophy and ischaemic/reperfusion injury

Basic Research in Cardiology

Volumn 100, Issue 4, 2005, Pages 346-354

  du Toit, Eugene F ^a   Nabben, Marinda ^a   Lochner, Amanda ^a  

^a UNIVERSITY OF STELLENBOSCH   (South Africa)

Author keywords

Angiotensin II; Cardiac function; Ischaemia; Losartan; Obesity

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOSARTAN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ANGIOTENSIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA FLOW; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; BLOOD SAMPLING; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; HEART FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE ISCHEMIA; HEART PERFUSION; HEART WEIGHT; MALE; NONHUMAN; OBESITY; PATHOPHYSIOLOGY; RAT; REPERFUSION INJURY; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

ANGIOTENSIN II; ANIMALS; BLOOD GLUCOSE; CARDIAC OUTPUT; CARDIOMEGALY; MALE; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; OBESITY; RATS; RATS, WISTAR; TUMOR NECROSIS FACTOR-ALPHA; VENTRICULAR REMODELING;

EID: 22144460505     PISSN: 03008428     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00395-005-0528-5     Document Type: Article

References (45)

1. Alaud-Din A, Meterissian R, Lisbona R, McClean LD, Forse RA (1990) Assessment of cardiac function in patients who were morbidly obese. Surgery 108:809-818 1:STN:280:By6D3Mboslw%3D
2. Bayorh MA, Ganafa AA, Socci R, Eatman D, Silvestrov N, Abukhalaf IK (2003) Effect of losartan on oxidative stressinduced hypertension in Sprague-Dawley rats. AJH 16:387-392 10.1016/S0895-7061(03)00054-2
3. Bendall JK, Cave AC, Heymes C, Gall N, Shah AM (2002) Pivotal role of a gp91 phox-containing NADPH oxidase in angiotensin II-induced cardiac hypertrophy in mice. Circulation 105:293-296 10.1161/hc0302.103712
4. Boustany CM, Bharadwaj K, Daugherty A, Brown DR, Randall DC, Cassis LA (2004) Activation of the systemic and adipose renin-angiotensin system in rats with diet-induced obesity and hypertension. Am J Physiol 287:R943-R949 1:CAS:528:DC%2BD2cXptF2mu78%3D
5. Bunag RD (1973) Validation in awake rats of a tail-cuff method for measuring systolic blood pressure. J Appl Physiol 34:279-282 1:STN:280:CSyD1MvpslA%3D
6. Byrne JA, Grieve DJ, Bendall JK, Li JM, Gove C, Lambeth JD, Cave AC, Shah AM (2003) Contrasting roles of NADPH oxidase isoforms in pressure overload versus angiotensin II-induced cardiac hypertrophy. Circ Res 93:802-804 10.1161/01.RES.0000099504.30207.F5
7. Cerbai E, Crucitti A, Sartiani L et al. (2000) Long-term treatment of spontaneously hypertensive rats with losartan and electrophysiological remodelling of cardiac myocytes. Cardiovasc Res 45:388-396 10.1016/ S0008-6363(99)00344-2
8. Dahlhof B (2001) Left ventricular hypertrophy and angiotensin II antagonists. Am J Hypert 14:174-182 10.1016/S0895-7061(00)01257-7
9. De Devitiis O, Fazio S, Petitto M, Maddalena G, Contaldo F, Mancini M (1981) Obesity and cardiac function. Circulation 64:477-482 7261280
10. De Lano FA, Balete R, Schmid-Schonbein GW (2005) Control of oxidative stress in microcirculation of spontaneously hypertensive rats. Am J Physiol 288:H805-H812 1:CAS:528:DC%2BD2MXhsFemu7o%3D
11. Dostal DE (2000) The cardiac reninangiotensin system: Novel signalling mechanisms related to cardiac growth and function. Regulatory Peptides 91:1-11 10.1016/S0167-0115(99)00123-8
12. Ferdinandy P, Danial H, Ambrus I, Rothery RA, Schulz R (2000) Peroxynitrite is a major contributor to cytokine-induced myocardial contractile failure. Circ Res 87:241-247 1:CAS:528:DC%2BD3cXlsFygs7g%3D
13. Frolkis I, Gurevitch J Yuhas Y et al. (2001) Interaction between paracrine tumor necrosis factor - alpha and paracrine angiotensin II during myocardial ischaemia. J Am Coll Cardiol 37:316-322 10.1016/ S0735-1097(00)01055-X
14. Giacchetti G, Faloia E, Mariniello B, Sardu C, Gatti C, Camilloni MA, Guerrieri M, Mantero F (2002) Overexpression of the renin-angiotensin system in human visceral adipose tissue in normal and overweight subjects. Am J Hypertens 15:381-388 10.1016/S0895-7061(02)02257-4
15. Gordon T, Kannel WB (1976) Obesity and cardiovascular diseases: The Framingham study. Clin Endocrinol Metab 5:367-375 10.1016/ S0300-595X(76)80026-6
16. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW (1994) Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 74:1141-1148 1:CAS:528:DyaK2cXksFSlu7s%3D
17. Gurevitch J, Froklis I, Yuhas Y et al. (1997) Anti-TNF-α improves myocardial recovery following ischaemia and reperfusion. J Am Coll Cardiol 30:1554-1561 10.1016/S0735-1097(97)00328-8
18. Higuchi Y, Otsu K, Nishida K, Hirotani S, Nakayama H, Yamaguchi O, Matsumura Y, Ueno H, Tada M, Hori M (2002) Involvement of reactive oxygen species mediated NF-kappa B activation in TNFalpha- induced cardiomyocyte hypertrophy. J Mol Cell Cardiol 34:233-240 10.1006/ jmcc.2001.1505
19. Hofmann C, Lorenz K, Braithwaite SS et al. (1994) Altered gene expression for tumor necrosis factor-alpha and its receptors during drug and dietary modulation of insulin resistance. Endocrinology 134:264-270 10.1210/en.134.1.264
20. Hotamisligil GS, Arner P, Caro JF et al. (1995) Increased adipose tissue expression of tumor necrosis factor alpha in human obesity and insulin resistance. J Clin Invest 95:2409-2415 1:CAS:528:DyaK2MXltlWru70%3D
21. 1 receptor blockade in experimental myocardial ischaemia/reperfusion. Basic Res Cardiol 93:85-91 10.1007/s003950050226
22. Kalra D, Sivasubramanian N, Mann DL (2002) Angiotensin II induces TNFα biosynthesis in the adult mammalian heart through a protein kinase-C dependent pathway. Circulation 105:2198-2205 10.1161/ 01.CIR.0000015603.84788.47
23. Kapadia SR, Oral H, Lee J, Nakano M, Taffet GE, Mann DL, 1997 Hemodynamic regulation of tumor necrosis factor alpha gene and protein expression in adult feline myocardium. Circ Res 81:187-195
24. Kawano H, Do YS, Kawano Y, Starnes V, Barr M, Law RE, Hsueh WA (2000) Angiotensin II has multiple profibrotic effects in human cardiac fibroblasts. Circulation 101:1130-1137 1:CAS:528:DC%2BD3cXit1aks7k%3D
25. Kupatt C, Habazettl H, Goedecke A, Wolf DA, Zahler S, Boekstegers P, Kelly RA, Becker BF (1999) Tumor necrosis factoralpha contributes to ischemia- and reperfusion- induced endothelial activation in isolated hearts. Circ Res 84:392-400 1:CAS:528:DyaK1MXhs12lsL0%3D
26. Kuwahara K, Saito Y, Harada M, Ishikawa M, Ogawa E, Miyamoto, Y, Hamanake et al. (1999). Involvement of cardiotrophin- 1 in cardiac myocyte-nonmyocyte interactions during hypertrophy of rat cardiac myocytes in vitro. Circulation 100:1116-1124 1:CAS:528:DyaK1MXmt1Whs7g%3D
27. Lijnen PJ, Petrov VV, Fugard RH (2000) Induction of cardiac fibrosis by angiotensin II. Methods Find Exp Clin Pharmacol 2:709-723
28. Meldrum DR, Meng X, Dinarello CA, Ayala A, Cain BS, Shames BD, Ao L, Banerjee A, Harken AH (1998) Human myocardial tissue TNF expression following acute global ischemia in vivo. J Mol Cell Cardiol 30:1683-1689 10.1006/jmcc.1998.0776
29. Naik, GOA, Moe GW, Armstrong PW (2001) Specific and non-specific measurements of tissue angiotensin II cascade members. J Pharm Biomed Anal 24:947-955 10.1016/S0731-7085(00)00565-3
30. Nakumara K, Fushimi K, Kouchi H, Mihara K, Ohe T, Namba M (1998) Inhibitory effect of antioxidants on neonatal rat cardiac myocyte hypertrophy induced by tumor necrosis factor a and angiotensin II. Circulation 98:794-799 9727550
31. Ono K, Matsumori A, Shioi T, Furukawa Y, Sasayama S (1998) Cytokine gene expression after myocardial infarction in rat hearts. Circulation 98:149-156 1:CAS:528:DyaK1cXkvVSqu7c%3D
32. Paulson DJ, Tahiliani AG (1992) Cardiovascular abnormalities associated with human and rodent obesity. Life Sciences 51:1557-1569 10.1016/ 0024-3205(92)90618-Y
33. Peterson LR, Waggoner AD, Schechtman KB et al. (2004) Alterations in left ventricular structure and function in young healthy obese women. J Am Coll Cardiol 43:1399-1404 10.1016/j.jacc.2003.10.062
34. Pickavance L, Tadayyon M, Widdowson PS et al. (1999) Therapeutic index for rosiglitazone in dietary obese rats: Separation of efficacy and haemodilution. B J Pharmacol 128:1570-1576 10.1038/sj.bjp.0702932
35. Smits JFM, van Krimpen C, Schoemaker RG, Cleutjens JPM, Daemen MJAP (1992) Angiotensin II receptor blockade after myocardial infarction in rats: Effects of haemodynamics, myocardial DNA synthesis, and interstitial collagen content. J Cardiovasc Pharmacol 20:660-673
36. Sun Y, Ratajska A, Weber KT (1995) Inhibition of angiotensin converting enzyme and attenuation of myocardial fibrosis by lisinopril in rats receiving Angiotensin II. J Lab Clin Med 126:95-101 1:CAS:528:DyaK2MXnsF2mtLk%3D
37. Sun Y, Zhang J, Bedigian MP, Robinson AD, Weber KT (2004) Tissue angiotensin II in the regulation of inflammatory and fibrogenic components of repair in the rat heart. J Lab Clin Med 143:41-51 10.1016/ j.lab.2003.07.004
38. Weber KT (1989) Angiotensin and the remodelling of the myocardium. Br J Clin Pharmacol 28 Suppl 2:141S-149S 1:CAS:528:DyaK3cXhs1ensw%3D%3D
39. WHO, The World Health Report 1998: Life in the 21st century, World Health Organisation, Geneva, 1998
40. Wu L, Wang R, de Champlain J, Wilson T (2004) Beneficial and deleterious effects of rosiglitazone on hypertension development in spontaneously hypertensive rats. AJH 17:749-756 10.1016/j.amjhyper.2004.04.010
41. Yahia DA, MadaniS, Prost J, Bouchenak M, Belleville J (2005) Fish protein improves blood pressure but alters HDL2 and HDL3 composition and tissue lipoprotein lipase activities in spontaneously hypertensive rats. Eur J Nutr 44:10-17 10.1007/s00394-004-0486-y
42. Yokoyama T, Nakano M, Bednarczyk JL, McIntyre BW, Entman M, Mann DL (1997) Tumor necrosis factor α provokes a hypertrophic growth response in adult cardiac myocytes. Circulation 95:1252-1257
43. Youn TJ, Kim HS, Oh BH (1999) Ventricular remodelling and transforming growth factor-beta 1 mRNA expression after nontransmural myocardial infarction in rats: Effects of angiotensin converting enzyme inhibition and angiotensin type 1 receptor blockade. Basic Res Cardiol 94:246-253 10.1007/s003950050149
44. Yu G, Liang X, Xie X, Su M, Zhao S (2001) Diverse effects of chronic treatment with losartan, fosinopril, and amlodipine on apoptosis, angiotensin II in left ventricle of hypertensive rats. Intern J Cardiol 81:123-129 10.1016/S0167-5273(01)00539-3
45. Yu G, Liang X, Xie X, Su M, Zhao S (2002) Apoptosis, myocardial fibrosis and angiotensin II in the left ventricle of hypertensive rats treated with fosinopril or losartan. Chin Med J 115:1287-1291 1:CAS:528:DC%2BD38Xot1Wlsb4%3D